Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG-F4 in Advanced Colorectal or Pancreatic Cancer
NCT06436976Phase 2Recruiting
- Sponsor
- Chungnam National University Hospital
- Start
- Mar 2024
- Primary completion
- Dec 2024
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus reuteri ATG-F4 in cachexia, sponsored by Chungnam National University Hospital. Started Mar 2024; status: recruiting.
02
Drugs
lactobacillus reuteri ATG-F4
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT06436976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06436976.